CYTOKINETICS, INCORPORATED (CYTK) Return on equity 2016–2021
CYTOKINETICS, INCORPORATED (CYTK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-88.3%FY2021 · since FY2016: 17.4% → -88.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -88.3% | +24.0 pp |
| FY2020 | -112.3% | — |
| FY2018 | -409.8% | -293.5 pp |
| FY2017 | -116.3% | -133.8 pp |
| FY2016 | 17.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating incomeCYTK Operating marginCYTK Operating cash flowCYTK Free cash flowCYTK Capital expendituresCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Total liabilitiesCYTK Shareholders’ equityCYTK overview →